Divi’s Laboratories shares have a 6-7% downside from the current levels according to analyst estimates. While a lack of enough positive technical triggers is at play according to technical analysts, the company's current fundamentals are also a "work in progress for better outlook", brokerage firm Motilal Oswal noted in its report.